Pulsed dye laser effective on port-wine stains in infants

Pulsed dye laser effective on port-Wine stains in infants

(HealthDay) -- Pulsed dye laser (PDL) treatment at two-, three-, and four-week intervals is effective for infants with facial port-wine stains (PWS), with minimal short-term side effects, according to a study published online Feb. 20 in the Journal of the American Academy of Dermatology.

Robert Anolik, M.D., of the & Skin Surgery Center of New York in New York City, and colleagues retrospectively reviewed the charts of 24 with facial PWS who received at least five treatments with the PDL at two-, three-, and four-week intervals at a private laser and skin surgery center.

The researchers found that side effects were similar in all interval groups and included short-term erythema, edema, purpura, and mild post-inflammatory hyperpigmentation. No cases of hypopigmentation, scarring, or infection were reported. All interval groups showed 50 to 100 percent clearance of their PWS after five treatments. Six of eight (75 percent) and seven of eight (88 percent) patients in the two- and three-week interval groups, respectively, experienced complete or near-complete clearance, compared with three of eight (38 percent) patients in the four-week interval group.

"We conclude that PDL treatments at two-, three-, and four-week intervals are effective for the management of facial PWS in infants, with minimal short-term ," the authors write.

Several authors disclosed financial ties to medical device companies.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Plastic surgery gives younger appearance to aging face

Feb 21, 2012

(HealthDay) -- Aesthetic facial plastic surgery results in a reduction in perceived age, with the effect more substantial for those who undergo multiple procedures, according to a study published online Feb. ...

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.